Auson Pharmaceuticals (002755.SZ) subsidiary Maripavipan tablets obtained a drug registration certificate.

Zhijiancai News, Ausaikang (002755.SZ) announced that its wholly-owned subsidiary, Jiangsu Ausaikang Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" for Maviret tablets issued by the National Medical Products Administration. The drug is classified as a Class 4 chemical drug, and obtaining the "Drug Registration Certificate" is considered equivalent to passing consistency evaluation. This will further expand the company's pipeline in the field of anti-infection and enhance its competitiveness in this area.